Due to the malignant nature of gliomas, most of the patients in group 2 were also classified as immune C4 (lymphocyte depleted) subtype, while only a few were classified as C1 (wound healing) subtype and immune C6 (TGF-beta dominant) subtype (Fig. 3B). Here, C4A is linked to glioma.